Compare PGEN & XYF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | PGEN | XYF |
|---|---|---|
| Founded | 1998 | 2014 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Finance: Consumer Services |
| Sector | Health Care | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.2B | 207.6M |
| IPO Year | 2013 | 2018 |
| Metric | PGEN | XYF |
|---|---|---|
| Price | $6.84 | $5.53 |
| Analyst Decision | Buy | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $8.33 | N/A |
| AVG Volume (30 Days) | ★ 4.6M | 69.7K |
| Earning Date | 05-13-2026 | 05-18-2026 |
| Dividend Yield | N/A | ★ 11.34% |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.03 | N/A |
| Revenue | ★ $230,981,000.00 | N/A |
| Revenue This Year | $1,115.92 | N/A |
| Revenue Next Year | $81.04 | N/A |
| P/E Ratio | $229.00 | ★ $0.90 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $2.99 | $3.30 |
| 52 Week High | $7.72 | $15.58 |
| Indicator | PGEN | XYF |
|---|---|---|
| Relative Strength Index (RSI) | 51.21 | 55.72 |
| Support Level | $6.60 | $5.44 |
| Resistance Level | $7.32 | $5.65 |
| Average True Range (ATR) | 0.31 | 0.29 |
| MACD | -0.09 | -0.02 |
| Stochastic Oscillator | 18.27 | 59.38 |
Precigen Inc is a commercial-stage biopharmaceutical company focused on developing precision medicines to improve the lives of patients, targeting immuno-oncology, autoimmune disorders, and infectious diseases using its proprietary and complementary technology platforms. These platforms support the development of gene programs, delivery through viral, non-viral, and microbe-based approaches, and control of gene expression for safety and efficacy. Its key platforms include AdenoVerse immunotherapy and UltraCAR-T, supported by the UltraPorator device for rapid and cost-effective manufacturing. Its clinical pipeline includes PRGN-2009, PRGN-3005, PRGN-3006, and PRGN-3007. Its reportable segments are Biopharmaceuticals and Exemplar.
X Financial is a Cayman Islands-based technology-driven personal finance company. Along with its subsidiaries, the firm provides diversified investment opportunities to investors in China through its wealth management platform, Xiaoying Wealth Management. Loan products offered by the company include Xiaoying Card Loan, Xiaoying Preferred Loan, and Xiaoying Housing Loan. The company generates revenue from loan facilitation service, post-origination service, guarantee services provided and financing income.